Current trends in the treatment of bronchial asthma
- Authors: Kurbacheva O.M.1, Isakova I.I.1
-
Affiliations:
- National Research Center - Institute of Immunology
- Issue: Vol 21, No 3 (2019)
- Pages: 41-44
- Section: Articles
- URL: https://journals.rcsi.science/2075-1753/article/view/96882
- DOI: https://doi.org/10.26442/20751753.2019.3.190182
- ID: 96882
Cite item
Full Text
Abstract
Bronchial asthma is a widespread disease of the respiratory system, has a significant impact on the quality of life of patients. The main objectives of the treatment of asthma is to achieve symptom control, prevent exacerbations and prevent the development of complications. The article describes approaches to the management of patients with severe asthma, the use of monoclonal antibodies in the treatment of asthma.
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
Oksana M. Kurbacheva
National Research Center - Institute of Immunology
Email: kurbacheva@gmail.com
D. Sci. (Med.), Full Prof. Moscow, Russia
Irina I. Isakova
National Research Center - Institute of Immunologyallergist-immunologist Moscow, Russia
References
- Global Strategy for Asthma Management and Prevention. Revised 2018. www.ginasthma.com
- Сhuchalin A.G, Khaltaev N, Antonov N. Chronic respiratory diseases and risk factors in 12 regions of the Russian Federation. Int J COPD 2014; 9: 963-74.
- Bousqet J, Mantzouranis E, Cruz A.A et al. Uniform definition of asthma severity, control and exacerbitions: document presented for the World Health Organization Consultation on Severe Asthma. J Allergy Clin Immunol 2010; 126: 926-38.
- Федеральные клинические рекомендации по диагностике и лечению бронхиальной астмы. 2013.
- Cazzola M, Page C.P, Rogliani P, Matera M.G. b2-Agonist therapy in lung disease. Am J Respir Crit Care Med 2013; 187: 690-6.
- Powell H, Cibson P.G. Inhaled corticosteroid doses in asthma: an evidence-based approach. Med J Aust 2003; 178: 223-5.
- Powell H, Cibson P. High dose versus low dose inhaled corticosteroid as initial starting dose for asthma in adults and children (reviev). Cochrane Database Syst Rev 2003; 4: 223-5.
- Paggiaro P, Bacci E. Montelukast in asthma: a review of its efficacy and plase in therapy. Ther Advanc Chronic Dis 2010; 2: 47-58. doi: 10.1177/2040622310383343
- Stephenson L. Monoclonal Antibody Therapy for Asthma. Clin Pulm Med 2017; 24: 250-7.
- Инструкция по применению лекарственного препарата для медицинского применения Ксолар (ЛСР-000082 от 29.05.2007).
- Alhossan A, Lee C.S, MacDonald K et al. "Real-life" Effectiveness Studies of Omalizumab in Adult Patients with Severe Allergic Asthma: Meta-analysis. Allergy Clin Immunol Pract 2017; 5: 1362-70.
- Corren J, Kavati A, Ortiz B et al. Efficacy and safety of omalizumab in children and adolescents with moderate-to-severe asthma: A systematic literature review. Allergy Asthma Proc 2017; 38: 250-63.
- Инструкция по медицинскому применению препарата Синкейро (реслизумаб). [Instruktsiia po meditsinskomu primeneniiu preparata Sinkeiro (reslizumab) (in Russian).]
- Ortega H.G, Yansey S.W, Mayer B et al. Severe eosinophilic asthma treated with mepolizumab stratified by baseline eosinophil thresholds: a secondary analysis of the DREAM and MENSA studies. Lancet Respir Med 2016; 4: 549-56.
- Инструкция по применению препарата Нукала. Рег. №ЛП-004794. [Instruktsiia po primeneniiu preparata Nukala. Reg. №LP-004794 (in Russian).]
- Bel E.H, Wenzel S.E, Thompson J. et al. NEJM 2014; 371 (13): 1189-97.
- Domingo C. Overlapping Effects of Monoclonal Antibodies for Severe Asthma. Drugs 2017. doi: 10.1007/s40265-017-0810-5
Supplementary files
